| HSV reactivation (n = 40) | CMV reactivation (n = 7) | HSV and CMV reactivation (n = 20) | Non reactivation (n = 56) |
---|---|---|---|---|
Duration of mechanical ventilatione (days) | 29 (19.5–41)a,b | 28 (20.5–37)a,b | 58.5 (38–72.3)a,c,d | 17.5 (9–28)b,c,d |
Ventilator-free days at D28e (days) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) |
Weaned from ECMO (%) | 23 (58) | 2 (29) | 15 (75) | 27 (48) |
Duration of ECMOe (days) | 14 (9.75–20)a | 13 (9.5–16) | 19.5 (10.75–33)a | 9 (5–14)b,c |
ECMO-free days at D28e (days) | 0 (0–16) | 0 (0–7) | 5.5 (0–17.25) | 0 (0–17) |
ICU mortality (%) | 20 (50) | 5 (71) | 9 (45) | 33 (59) |
Hospital mortality (%) | 20 (50) | 5 (71) | 10 (50) | 33 (59) |
ICU length of staye (days) | 27.5 (17.75–35.5)b | 29 (20–30.5)b | 51.5 (32.5–69)a,c,d | 16 (8.75–30.25)b |
Hospital length of staye (days) | 35 (26.75–56)b | 29 (23–44) | 70 (43.5–87)a,c | 24 (11–43)b |